Black and mixed-race skin has specific biological characteristics. Not flaws, not fragilities — but particularities that deserve a tailored approach rather than products designed for other phototypes.
Yet, the majority of available skincare advice has been developed for fair phototypes. The result: generic recommendations that ignore what makes these skin types unique, and frequent mistakes with consequences that are sometimes difficult to correct.
An effective routine for high phototype skin is not improvised. It is built upon what the biology of this skin truly requires.
What biologically distinguishes high phototype skin
Black and mixed-race skin (phototypes IV, V, and VI) has more active melanocytes that produce more melanin. This melanin, primarily eumelanin, offers superior natural protection against UV damage — a phototype VI can have a natural SPF estimated between 10 and 15. The direct consequence: solar aging is slower, and expression lines appear later.
But this same melanocytic reactivity creates a specific vulnerability: post-inflammatory hyperpigmentation. Any inflammation, even minor — a pimple, irritation, friction, unsuitable care — can trigger localized melanin overproduction that leaves a persistent mark long after the initial lesion has disappeared.
The skin barrier also exhibits distinct characteristics: a higher ceramide content but greater transepidermal water loss (TEWL) in some studies, particularly on very dark skin. The skin may appear oily on the surface while being more prone to dehydration in deeper layers.
The most frequent issues for these phototypes
Post-inflammatory hyperpigmentation (PIH) is the number one concern. It affects up to 65% of dark-skinned patients consulting for skin problems. Acne, eczema, shaving, hair removal, overly aggressive care: each aggression can leave a pigmentary mark that takes months to fade without appropriate management.
Seborrheic dermatitis and scalp problems are more frequent in these phototypes and often underdiagnosed. Scales on dark skin are less visible, but itching and inflammation are very much present.
Keloids: keloid scarring, which produces hypertrophic scars extending beyond the wound edges, is significantly more frequent in high phototypes. This point is essential to consider before any invasive aesthetic procedure.
Ashy skin: the grayish tint that appears on dry or dehydrated skin is more visible on dark skin and often wrongly interpreted as a fundamental problem. It is dehydration of the stratum corneum, reversible with appropriate hydration.
Routine mistakes that worsen these problems
Over-exfoliating is the most frequent and counterproductive mistake. Excessive exfoliation weakens the barrier, triggers inflammation, and precisely stimulates the melanocytes we are trying to calm. On these phototypes, every irritation is a potential spot.
Using unsuitable lightening products: prolonged self-medication with hydroquinone can cause exogenous ochronosis, a paradoxical, irreversible bluish-gray pigmentation. Its use must be medical and supervised.
Neglecting sun protection on the grounds that "dark skin is naturally protected": natural SPF is not enough to prevent the aggravation of spots by UV rays. Without photoprotection, no depigmenting treatment can work properly.
Actives truly suited for these phototypes
Azelaic acid is the reference depigmenting active: it inhibits tyrosinase, acts on inflammation, and presents no risk of paradoxical hyperpigmentation. It is the first active to integrate into an anti-spot routine for dark skin.
Niacinamide between 5 and 10% reduces melanin transfer to keratinocytes, strengthens the barrier, and soothes inflammation. Versatile and well-tolerated, it can be integrated into all routines.
Alpha-arbutin inhibits tyrosinase stably and progressively, without irritation. Particularly suitable for maintenance phases or for skin that does not tolerate acids.
Stabilized vitamin C (ascorbyl glucoside, sodium ascorbyl phosphate) has better tolerance than L-ascorbic acid on reactive skin, with documented action on melanogenesis and oxidative stress.
Low-concentration AHAs (glycolic acid 5 to 8%, lactic acid) can accelerate cell renewal and improve radiance, provided they are introduced gradually and combined with rigorous photoprotection.
The fundamental rule: control inflammation above all else
On high phototype skin, treating a spot without controlling what produces it is like emptying a bathtub with the tap running. Any effective anti-spot routine begins by reducing inflammation, strengthening the barrier, and eliminating sources of irritation. Depigmenting actives then follow, gradually, on stabilized skin.
The Paradermia approach
Our pharmacist takes into account the specificities of high phototypes in each protocol. Products are selected for their real effectiveness on these phototypes and their long-term tolerance. No irritating active is integrated without a prior phase of barrier strengthening.
Frequently asked questions
Can I find a suitable routine for my black or mixed-race skin on Paradermia?
Yes. Our pharmacist offers protocols built on the biological specificities of high phototypes: PIH prevention, adapted depigmenting actives, barrier strengthening, and photoprotection. Each recommendation takes into account your specific profile and your objectives.
Is SPF really necessary for dark skin?
Yes, systematically. The natural protection of high phototypes reduces the risk of sunburn but does not prevent the aggravation of pigmentary spots by UV rays. Daily SPF 50 is the most effective measure to allow depigmenting actives to work and prevent the recurrence of treated spots.
How long does it take for a PIH spot to disappear?
Epidermal spots generally respond in 2 to 4 months with an adapted routine and rigorous photoprotection. Deeper dermal spots require longer treatment and sometimes dermatological advice.
Sources
- Davis E.C, Callender V.D. (2010). Postinflammatory hyperpigmentation: a review of the epidemiology, clinical features, and treatment options in skin of color. The Journal of Clinical and Aesthetic Dermatology. PMID:20725554
- Kaidbey K.H, Agin P.P, Sayre R.M, Kligman A.M. (1979). Photoprotection by melanin — a comparison of black and Caucasian skin. Journal of the American Academy of Dermatology. doi:10.1016/S0190-9622(79)70018-1
- Feng X, Shang J, Gu Z, et al. (2024). Azelaic acid: mechanisms of action and clinical applications. Clinical, Cosmetic and Investigational Dermatology. doi:10.2147/CCID.S485237
- Hakozaki T, Minwalla L, Zhuang J, et al. (2002). The effect of niacinamide on reducing cutaneous pigmentation and suppression of melanosome transfer. British Journal of Dermatology. doi:10.1046/j.1365-2133.2002.04834.x
- Lazar M, De La Garza H, Vashi N.A. (2023). Exogenous ochronosis: characterizing a rare disorder in skin of color. Journal of Clinical Medicine. doi:10.3390/jcm12134341